Search

Your search keyword '"Diane A"' showing total 3,307 results

Search Constraints

Start Over You searched for: Author "Diane A" Remove constraint Author: "Diane A" Journal blood Remove constraint Journal: blood
3,307 results on '"Diane A"'

Search Results

3. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

4. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

5. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy

6. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

7. Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma

10. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

11. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis

12. p53 activation during ribosome biogenesis regulates normal erythroid differentiation

13. PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

14. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF

16. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation

18. Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

20. Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma

22. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

23. Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

25. Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3

26. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

28. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma

30. Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy

32. A Systematic Meta-Analysis of Cytokine Release Syndrome Incidence in B-Cell Maturation Antigen-Targeting Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Patients with Relapsed and/or Refractory Multiple Myeloma

34. Pharmacological Characterization of JNJ-75276617, a Menin-KMT2A Inhibitor, As Targeted Treatment for KMT2A-Altered and NPM1-Mutant Acute Leukemia

36. CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells

38. Impact of Transfusion Program during Pregnancy on the Obstetrical Outcomes in Sickle Cell Disease Women

39. Higher-order connections between stereotyped subsets

40. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy

43. A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

44. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

46. Pharmacological Characterization of JNJ-75276617, a Menin-KMT2A Inhibitor, As Targeted Treatment for KMT2A-Altered and NPM1-Mutant Acute Leukemia

47. CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells

Catalog

Books, media, physical & digital resources